Drugmakers, banks lead U.S. markets down

This is an archived article that was published on sltrib.com in 2016, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

New York • Stocks are ending lower on Wall Street, led by drops in drugmakers and banks.

Mylan slumped 4 percent Thursday after senators called for an investigation into the company's pricing policies for the EpiPen allergy shot.

Banks fell as worries grew about Deutsche Bank, Germany's biggest lender. The bank's stock plunged 7 percent in heavy trading.

ConAgra, which makes Chef Boyardee products, jumped 8 percent after reporting strong results.

The Dow Jones industrial average fell 195 points, or 1 percent, to 18,143.

The Standard & Poor's 500 index fell 20 points, or 0.9 percent, to 2,151. The Nasdaq composite lost 49 points, or 0.9 percent, to 5,269.

Bond prices rose. The yield on the 10-year Treasury note fell to 1.56 percent.